乙衍生物的抗癌作用 素的乙衍生物的抗癌作用
Arkadiusz Sokal1,2, Patryk Mruczek1, Mateusz Niedoba2,3
1Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.
Molecules (Basel, Switzerland)
|February 26, 2025
概括
素是一种天然的抗癌化合物,看起来很有前途,但面临着生物可用性挑战. 衍生品和混合物,如氨酸-氨酸,增强其对抗乳腺癌,肺癌,前列腺癌和胃肠道癌症的有效性.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 氨酸是一种黄类化合物,具有抗癌性质,但具有较差的生物利用性和较低的溶解性,限制了临床使用.
- 化学修改,包括添加氨基,胺基,或基组到黄素骨架,可以改变生物活性.
- 混合化合物,以氨酸-氨酸为例,与单独氨酸相比,显示出更好的生物活性和生物可用性.
研究的目的:
- 审查辛及其衍生物的抗癌活性.
- 为了探索化学修饰对素疗效的影响.
- 突出混合化合物在癌症治疗中的潜力.
主要方法:
- 关于素及其衍生物的研究文献综述.
- 对修改的素结构和混合化合物研究的分析.
- 专注于针对特定癌症类型的抗癌活性.
主要成果:
- 素及其衍生物对各种人类癌症具有抗癌作用.
- 化学修饰和混合物形成可以提高素的生物可用性和功效.
- 氨酸-氨酸杂交体显示出优越的活性和生物可用性.
结论:
- 素衍生物和混合物代表了改善癌症治疗的有希望的策略.
- 对改性素化合物的进一步研究可能会导致新的治疗药物.
- 用这些化合物向乳腺,肺,前列腺和胃肠道癌症显示出显著的潜力.
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.5K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
507
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
507
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K


